WO2000049137B1 - Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell - Google Patents
Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cellInfo
- Publication number
- WO2000049137B1 WO2000049137B1 PCT/GB2000/000576 GB0000576W WO0049137B1 WO 2000049137 B1 WO2000049137 B1 WO 2000049137B1 GB 0000576 W GB0000576 W GB 0000576W WO 0049137 B1 WO0049137 B1 WO 0049137B1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell
- pluripotential
- embryonal
- tissue
- cell according
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0608—Germ cells
- C12N5/0611—Primordial germ cells, e.g. embryonic germ cells [EG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/04—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from germ cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/04—Cells produced using nuclear transfer
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
Abstract
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU25636/00A AU2563600A (en) | 1999-02-20 | 2000-02-18 | Pluripotential cells-2 |
JP2000599863A JP2003514509A (en) | 1999-02-20 | 2000-02-18 | Pluripotent functional cells-2 |
CA002371900A CA2371900A1 (en) | 1999-02-20 | 2000-02-18 | Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell |
EP00903886A EP1153123A2 (en) | 1999-02-20 | 2000-02-18 | Pluripotential cells-2 |
HK02102269.8A HK1040741A1 (en) | 1999-02-20 | 2002-03-26 | Pluripotential cells-2 |
HK02102672.9A HK1042112A1 (en) | 1999-02-20 | 2002-04-10 | Pluripotential cells-2 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9903804.4 | 1999-02-20 | ||
GBGB9903804.4A GB9903804D0 (en) | 1999-02-20 | 1999-02-20 | Pluripotential cells-2 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2000049137A2 WO2000049137A2 (en) | 2000-08-24 |
WO2000049137A3 WO2000049137A3 (en) | 2001-03-08 |
WO2000049137B1 true WO2000049137B1 (en) | 2001-05-17 |
Family
ID=10848084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2000/000576 WO2000049137A2 (en) | 1999-02-20 | 2000-02-18 | Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1153123A2 (en) |
JP (1) | JP2003514509A (en) |
AU (1) | AU2563600A (en) |
CA (1) | CA2371900A1 (en) |
GB (1) | GB9903804D0 (en) |
HK (2) | HK1040741A1 (en) |
WO (1) | WO2000049137A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002038741A1 (en) * | 2000-11-09 | 2002-05-16 | Bresagen Limited | Cell reprogramming |
JP2004248505A (en) * | 2001-09-21 | 2004-09-09 | Norio Nakatsuji | Undifferentiated fusion cell of somatic cell derived from es cell deficient in part or all of transplantation antigen and method for producing the same |
WO2003027277A1 (en) * | 2001-09-21 | 2003-04-03 | Japan Science And Technology Corporation | Method of screening reporgramming factor, reprogramming factor screened by the method, method of using the reprogramming factor, method of differentiating undifferentiated fused cells and method of constructing cell, tissues and organs |
US8647873B2 (en) | 2004-04-27 | 2014-02-11 | Viacyte, Inc. | PDX1 expressing endoderm |
AU2004309421B2 (en) | 2003-12-23 | 2011-04-21 | Viacyte, Inc. | Definitive endoderm |
CA2640644C (en) | 2006-01-31 | 2013-11-26 | Asubio Pharma Co., Ltd. | A method for purifying cardiomyocytes or programmed cardiomyocytes derived from stem cells or fetuses |
EP2014766A4 (en) | 2006-04-28 | 2009-12-02 | Asubio Pharma Co Ltd | Method for differentiation induction of myocardial cell from pluripotent stem cell |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9517780D0 (en) * | 1995-08-31 | 1995-11-01 | Roslin Inst Edinburgh | Biological manipulation |
-
1999
- 1999-02-20 GB GBGB9903804.4A patent/GB9903804D0/en not_active Ceased
-
2000
- 2000-02-18 EP EP00903886A patent/EP1153123A2/en not_active Withdrawn
- 2000-02-18 CA CA002371900A patent/CA2371900A1/en not_active Abandoned
- 2000-02-18 JP JP2000599863A patent/JP2003514509A/en active Pending
- 2000-02-18 AU AU25636/00A patent/AU2563600A/en not_active Abandoned
- 2000-02-18 WO PCT/GB2000/000576 patent/WO2000049137A2/en not_active Application Discontinuation
-
2002
- 2002-03-26 HK HK02102269.8A patent/HK1040741A1/en unknown
- 2002-04-10 HK HK02102672.9A patent/HK1042112A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
HK1042112A1 (en) | 2002-08-02 |
EP1153123A2 (en) | 2001-11-14 |
HK1040741A1 (en) | 2002-06-21 |
WO2000049137A2 (en) | 2000-08-24 |
CA2371900A1 (en) | 2000-08-24 |
GB9903804D0 (en) | 1999-04-14 |
AU2563600A (en) | 2000-09-04 |
WO2000049137A3 (en) | 2001-03-08 |
JP2003514509A (en) | 2003-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69837270T2 (en) | CORE TRANSFER WITH DIFFERENTIAL SOLIDS AND ADULTS DISPENSING CELLS | |
RU2322497C2 (en) | Isolated homozygous stem cell (variants), method for its preparing (variants), method for preparing required cell-ancestor, differentiated cell, group of differentiated cells or tissue type | |
US20130104253A1 (en) | Cytoplasmic transfer to de-differentiate recipient cells | |
NZ334016A (en) | Embryonic stem cell lines produced by cross species nuclear transplantation | |
US20040241838A1 (en) | Stem cells | |
JP2003512052A5 (en) | ||
JP2003514516A (en) | Gynogenetic or orogenic development of pluripotent cells and cell lines and their use for producing differentiated cells and tissues | |
US5032407A (en) | Gene transfer using transformed, neodetermined, embryonic cells | |
Kim et al. | Tissue engineering: the future of stem cells | |
WO2002024873A1 (en) | Stem cell therapy | |
AU2006227752B2 (en) | Skin substitutes with improved purity | |
WO2000049137B1 (en) | Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell | |
EP1237582B1 (en) | Methods for introducing genes into mammalian subjects | |
HK1023599A1 (en) | Cells for preventing graft rejection in transplantation and their uses. | |
Bongso et al. | The growth of inner cell mass cells from human blastocysts | |
Asal et al. | Stem cells: Sources, properties, and cell types | |
JP2005523685A (en) | Somatic embryonic stem cells and their differentiated progeny | |
WO2003083088A2 (en) | Stem cell therapy | |
WO2002063938A3 (en) | Production and use of dopaminergic cells to treat dopaminergic deficiencies | |
AU2564100A (en) | Pluripotential cells-1 | |
US20060035372A1 (en) | Stem-like cells | |
WO2023129418A1 (en) | Nonhuman stem cells and their use for production of cultured meat | |
Papadaki | Cardiac muscle tissue engineering | |
Rao | Alternatives to embryonic stem cells and cloning: a brief scientific overview | |
MXPA01002174A (en) | Primate embryonic stem cells with compatible histocompatibility genes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: B1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: B1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
B | Later publication of amended claims | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2000903886 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 25636/00 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2371900 Country of ref document: CA Ref country code: CA Ref document number: 2371900 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 599863 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 2000903886 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09913854 Country of ref document: US |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000903886 Country of ref document: EP |